{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:17:56Z","timestamp":1788952676423,"version":"build-2803163510"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214355","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T13:29:46Z","timestamp":1562333386000},"page":"e0214355","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":88,"title":["Sickle cell disease complications: Prevalence and resource utilization"],"prefix":"10.1371","volume":"14","author":[{"given":"Nirmish","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menaka","family":"Bhor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4689-8501","authenticated-orcid":true,"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincy","family":"Paulose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Yuce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle\u2010cell disease in the United States: national and state estimates","volume":"85","author":"DC Brousseau","year":"2010","journal-title":"Am J Hematol"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"KL Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"16","key":"ref3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Rees, DC. Sickle cell disease","volume":"376","author":"FB Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"9757","key":"ref4","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"DC Rees","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1535370216636726","article-title":"Minireview: genetic basis of heterogeneity and severity in sickle cell disease","volume":"241","author":"A Habara","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"D Zhang","year":"2016","journal-title":"Blood"},{"issue":"2","key":"ref7","first-page":"303","article-title":"Opportunities to improve outcomes in sickle cell disease","volume":"74","author":"SR Mehta","year":"2006","journal-title":"Am Fam Physician"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1745-7599.2009.00416.x","article-title":"Quality of life of adult patients with sickle cell disease","volume":"21","author":"V Mann\u2010Jiles","year":"2009","journal-title":"J Am Acad Nurse Pract"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1477-7525-3-50","article-title":"Health related quality of life in sickle cell patients: the PiSCES project","volume":"3","author":"DK McClish","year":"2005","journal-title":"Health Qual Life Outcomes"},{"issue":"41","key":"ref10","first-page":"2049","article-title":"Quality of life in children with sickle cell disease in Amsterdam area","volume":"43","author":"AP Kater","year":"1999","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"18","key":"ref11","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"SK Ballas","year":"2012","journal-title":"Blood"},{"issue":"7","key":"ref12","first-page":"1109","article-title":"Utilization of the office, hospital and emergency department for adult sickle cell patients: a five\u2010year study","volume":"98","author":"K Epstein","year":"2006","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"WR Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"ref14","first-page":"1349","article-title":"Approach to the vaso-occlusive crisis in adults with sickle cell disease","volume":"61","author":"SH Yale","year":"2000","journal-title":"Am Fam Physician"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/asheducation-2010.1.409","article-title":"Sickle-cell pain: advances in epidemiology and etiology","volume":"2010","author":"WR Smith","year":"2010","journal-title":"Hematolgy Am Soc Hematol Educ Program"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.21408","article-title":"The cost of health care for children and adults with sickle cell disease","volume":"84","author":"TL Kauf","year":"2009","journal-title":"Am J Hematol"},{"key":"ref17","article-title":"Sickle cell pain: progress in pain research and management","volume":"II","author":"SK Ballas","year":"1998"},{"issue":"23","key":"ref18","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. life expectancy and risk factors for early death","volume":"330","author":"OS Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pbc.22822","article-title":"Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea","volume":"56","author":"A Tripathi","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"13","key":"ref20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"DC Brousseau","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cpem.2018.05.005","article-title":"Sickle cell disease in the emergency department: complications and management","volume":"19","author":"CM Barriteau","year":"2018","journal-title":"Clin Pediatr Emerg Med"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"e26390","DOI":"10.1002\/pbc.26390","article-title":"Emergency department utilization by Californians with sickle cell disease, 2005\u20132014","volume":"64","author":"ST Paulukonis","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. rates and risk factors","volume":"325","author":"OS Platt","year":"1991","journal-title":"N Engl J Med"},{"issue":"19","key":"ref24","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/bloodadvances.2017007211","article-title":"Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review","volume":"1","author":"JWR Sins","year":"2017","journal-title":"Blood Adv"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","article-title":"Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises","volume":"95","author":"LJ Benjamin","year":"2000","journal-title":"Blood"},{"issue":"2\u20133","key":"ref26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/CH-189002","article-title":"Sickle cell disease: Classification of clinical complications and approaches to preventive and therapeutic management","volume":"68","author":"SK Ballas","year":"2018","journal-title":"Clinical hemorheology and microcirculation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T13:48:16Z","timestamp":1721483296000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214355"}},"subtitle":[],"editor":[{"given":"Lars-Peter","family":"Kamolz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214355","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/577189","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]}}}